Xiao C.

Xiao C. has had a diverse and extensive work experience in the life sciences industry. They started their career at Thermo Fisher Scientific, where they worked as a Field Application Scientist and later as a Sales Specialist. In these roles, Xiao was responsible for pre-sales demonstrations, post-sales training, and selling capital equipment and analysis software in Western NA and Texas.

Xiao then joined RareCyte, Inc. as a Sales Director for the Western NA region. They excelled in this role, exceeding sales goals and establishing RareCyte as a leading brand in the circulating tumor cell market. Xiao also took on the additional role of Country Manager of China during their time at RareCyte.

During a short period, Xiao worked as a High Content Screening Consultant where they provided consulting services.

After leaving RareCyte, Xiao joined Namocell as a Senior Director of Business Development for a brief period. They then returned to RareCyte as a Sales Director, this time focusing on the liquid biology platform in Western NA and APAC. They also took on the responsibility of market development for a new Spatial Biology platform in the same regions.

Most recently, Xiao rejoined RareCyte as a Sales Director for Spatial Biology in Western NA. In this role, they are responsible for developing key opinion leader advocates and educating stakeholders in the spatial biology space. Xiao also aims to develop early adopters and close instrumentation/consumable business.

Overall, Xiao C.'s work experience showcases their expertise in sales, business development, and market expansion in the life sciences industry.

Xiao C. started their education journey in 2004 at Case Western Reserve University, where they pursued a PhD in Nutrition. Xiao successfully completed their studies in 2008. Subsequently, from 2009 to 2011, Xiao C. attended the University of California, San Francisco, where they engaged in research as a Post-doctoral Research Scientist in the Department of Medicine. During this time, the specific field of study remains unknown.